A trial of an earlier, separate vaccine candidate, which was about to be tested on humans in South Africa as well as Kenya ...

Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But without US foreign aid dollars, its delivery to millions worldwide is under ...

Scientists believe they are on the cusp of a vaccine for HIV. Two promising vaccines were set to go to additional trials. But the vials of vaccines are in the freezer due to financial cuts by the ...

Trump’s pause in USAID spending has put major African HIV vaccine and prevention trials on hold, leaving the research world ...

A summary of current health news highlights a bird flu outbreak in Canada, halted HIV vaccine trials in South Africa, a legal ...

South African lab technician Nozipho Mlotshwa was waiting for the test results for a potential HIV vaccine, which has eluded scientists for decades, when the order came from USAID to stop work. The fi ...

Veteran vaccine researcher Arturo Casadevall gives a podcast primer on vaccinations, from how they work on a molecular level to common misconceptions ...

The development of a promising HIV vaccine led by South African researchers has been halted due to funding cuts from USAID, following U.S. President Donald Trump's policy changes. The vaccine program, ...

The FDA has accepted Gilead Sciences’ new drug application for lenacapavir as a long-lasting injectable to prevent HIV ...

A Brisbane man who took part in the University of Queensland’s aborted Covid vaccine trial is still returning “false positive” HIV tests four years later.

Supercomputer simulations have revealed how changes in the shape of the HIV-1 capsid protein may help the virus squeeze its ...